As expected, we observed that β-glucan treatment induced a higher level of IL-1β, IL-6, and IL-12p70 in tumor microenvironment, and the enhanced cytokines production was inhibited by alisertib (Figure 6H, Figure 6—figure supplement 1E). This evidence concerns the gene IL6 and neoplasm.